新的心脏保护剂K201是一种尿剂,增强了膜过率
1Division of Cardiovascular Diseases, Department of Internal Medicine, Mayo Clinic and College of Medicine, Rochester, MN 55905, USA. lisy.ondrej@mayo.edu
Circulation
|January 13, 2006
概括
心脏保护药物K201增强脏功能,作为一种强大的利尿和尿剂. 这项研究揭示了K201的存在.
科学领域:
- 药理学 药理学是指药理学的学科.
- 腎臟病學 (nephrology) 是一種神經病學.
- 心脏病学 心脏病学
背景情况:
- K201 (JTV519) 是一种新型的1,4-西胺药物,用于抗心律失常和心脏保护作用.
- K201稳定了心脏中的氨酸受体-释放通道 (RyR2).
- 在脏中存在RyR2,在脏血液动力学中具有潜在的作用,在体外研究中表明.
研究的目的:
- 调查K201的体内脏血液动力学和分泌作用.
- 为了确定心力衰竭药物K201是否具有功能增强的特性.
- 通过免疫组织化学方法在狗中识别RyR2的存在.
主要方法:
- 在正常麻醉的狗中,两剂 (0.1和0.5毫克/公斤) 的K201内注射.
- 测量脏血液动力学参数和分泌功能.
- 免疫组织化学检测脏组织中的RyR2表达.
主要成果:
- K201表现出强大的尿和利尿作用.
- 该药物增强了淋巴细胞过率和脏血液流动.
- 观察到远端管状的再吸收减少,平均动脉压暂时轻微下降.
结论:
- K201在脏中表现出显著的尿,利尿和血管扩张性质.
- 这些脏作用超出了已知的心肌效应.
- K201的性质可能有助于其在心力衰竭治疗中的治疗潜力.
相关概念视频
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
Heart Failure Drugs: Diuretics
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Glomerular Filtration Rate and its Regulation
The Glomerular Filtration Rate (GFR) is a measure of kidney function, reflecting the volume of filtrate formed per minute in the kidneys. On average, GFR is approximately 125 mL/min in males and 105 mL/min in females. Maintaining a relatively constant GFR is essential for the kidneys to effectively regulate body fluid homeostasis and maintain extracellular stability.
GFR regulation involves two primary intrinsic controls: the myogenic and tubuloglomerular feedback mechanisms.
The myogenic...
GFR regulation involves two primary intrinsic controls: the myogenic and tubuloglomerular feedback mechanisms.
The myogenic...
Renal Drug Excretion: Glomerular Filtration
The kidney serves as the primary organ responsible for eliminating drugs and their metabolites from the body. This process, known as renal elimination, starts with glomerular filtration and results in urine formation. Each kidney houses millions of functional units called nephrons, where urine production occurs. A nephron has two main components: a renal corpuscle and a renal tubule.
Drugs gain access to the kidney via the renal artery, which progressively branches off into afferent arterioles.
Drugs gain access to the kidney via the renal artery, which progressively branches off into afferent arterioles.
Drug Dosing in Renal Diseases: Measurement of Glomerular Filtration Rate
The glomerular filtration rate (GFR) is a critical indicator of kidney health, reflecting how well the kidneys filter blood. Changes in GFR can signal potential kidney impairment, necessitating accurate measurement methods to monitor kidney function effectively.Various molecules can serve as markers for GFR measurement, with the ideal marker meeting several specific criteria. It must freely filter at the glomerulus, avoid reabsorption or secretion by the renal tubules, remain unmetabolized, not...


